Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally since 2020. The nucleocapsid (N) protein plays a crucial role in the life cycle of SARS-CoV-2. The authors of an ...

In a recent study posted to bioRxiv*, researchers developed a screening platform and identified molecules with anti-coronavirus (anti-CoV) activity. Study: A screen for modulation of nucleocapsid ...

A cross-institutional effort between researchers at Weill Cornell Medicine and Duke University has yielded exciting progress in the search for new therapeutics against Covid-19. Where much of our ...

A new preprint study published in the medRxiv* preprint server found that nucleocapsid antigen in the blood (antigenemia) is a sensitive and specific biomarker for acute coronavirus disease 2019 ...

Filoviruses—such as Ebola and Marburg viruses—can cause hemorrhagic fevers with up to 90% lethality. Not only that, but there are very few tools (vaccines or drugs) to combat them. Now, scientists at ...

Digital generated image of circular pattern made out of Syringes with COVID-19 vaccine targeting into coronavirus cell on pink background. New research published in Science Translational Medicine ...

Scientists share detailed, complete images of a viral structure called the Ebola virus nucleocapsid. This breakthrough may accelerate the development of antivirals that target this viral structure to ...

Researchers investigated methods for measuring prior exposure in patients with suspected, undocumented COVID-19 infection to give better access to care and counsel. Researchers successfully detected ...

Despite the unprecedented global response to SARS-CoV-2, which has generated over 250,000 publications in two years, critical aspects of SARS-CoV-2 biology, pathogenesis, and immunomodulation remain ...

In this Application Note, Sartorius discusses and comprehensively characterizes the interaction between the SARS-CoV-2 Nucleocapsid (N) protein (presented as the first secreted human coronavirus viral ...